In addition, it was also found to promote hepatocellular carcinoma progression by repressing FOXO3a (Cao et al., 2018) or promoting glioma tumorigenesis by STAT3 activation (Xue et al., 2016). This evidence concerns the gene FOXO3 and glioma.